Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2001
10/18/2001WO2001077078A1 Novel pyridones and their use as modulators of serine hydrolase enzymes
10/18/2001WO2001077077A1 Substituted (hetero)aryl carboxamide derivatives as microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) secretion
10/18/2001WO2001077076A1 Novel naphthalene derivatives
10/18/2001WO2001076530A2 Il-8 receptor antagonists
10/18/2001WO2001038316A3 Sulfonyl oxazole amines and their use as 5-ht6 receptor ligands
10/18/2001WO2000035436A3 Treatment of arthritis with mek inhibitors
10/18/2001US20010031894 Metal-catalyzed arylations of hydrazines, hydrazones, and related substrates
10/18/2001US20010031874 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/18/2001US20010031870 Benzamide and sulfonamide substitued aminoguanidines and alkoxyguanidines as protese inhibitors
10/18/2001US20010031868 By reaction of a 2,5-diamino-4,6-dihalopyrimidine with formic acid
10/18/2001US20010031858 Coupling of 2-(2-acetylamino-3-(4-amidinophenyl) propionylamino)-2-cyclohexylacetic acid with a 3-(2-amino-2-carbamoylethyl)-1-methylpyridinium salt or a salt thereof; anticoagulants
10/18/2001US20010031788 Anticancer agents, osteoporosis, arteriosclerosis, restnosis,vision defects
10/18/2001US20010031779 Methods and materials for treating and preventing inflammation of mucosal tissue
10/18/2001US20010031771 Administering n-heteroaryloxyalkylamines and arylthioalkyl amines as agonists of nicotinic receptos used in the treatment of central nervous system disorders
10/18/2001US20010031770 Pyridoxal analogues and methods of treatment
10/18/2001CA2405306A1 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
10/17/2001EP1146030A2 Combinatorial synthesis and analysis of organometallic compounds and catalysts
10/17/2001EP1144423A1 Bis-terpyridine-platinum(ii) complexes
10/17/2001EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1144380A1 A meta-nitro phenol derivative and a process for producing it
10/17/2001EP1144379A1 Low-dusting, flowable aminopyridine products
10/17/2001EP1144375A2 Synthesis of oligoketides
10/17/2001EP1144370A2 Thyroid receptor ligands
10/17/2001EP1144369A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
10/17/2001EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001EP1144365A2 Inhibitors of alpha-4 beta-1 mediated cell adhesion
10/17/2001EP1144364A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1144362A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
10/17/2001EP1144360A1 A method for the synthesis of compounds of formula 1 and derivatives thereof
10/17/2001EP1144348A2 Lta 4? hydrolase inhibitors
10/17/2001EP1143974A1 Pharmaceutical compositions for alleviating discomfort
10/17/2001EP1143970A1 Pyridine compounds, use and preparation thereof
10/17/2001EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001EP1143957A2 Treatment of arthritis with mek inhibitors
10/17/2001EP1143916A2 Topical compositions comprising protected functional thiols
10/17/2001EP0950049B1 Diphenyl alkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them
10/17/2001EP0935486B1 Aqueous film-forming foam compositions
10/17/2001EP0808103A4 Protein hydroxylation inhibitors for fibroproliferative disorders
10/17/2001EP0754682B1 Aminostilbazole derivative and medicine
10/17/2001EP0640065B1 Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation
10/17/2001CN1318056A Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof
10/17/2001CN1318055A Pyridine ketones useful as herbicides
10/17/2001CN1318054A Novel compounds
10/17/2001CN1318051A Novel urea derivatives bearing nitrogenous aromatic heterocycles
10/17/2001CN1073111C Process for preparation of 2,3-pyridinedicarboximides
10/17/2001CN1073103C Compounds and compsns. for treating diseases associated with tryptase activity
10/17/2001CN1073090C 1,3,4-oxadiazine derivatives and their use as pesticides
10/16/2001US6303816 N-2-(4-(4-(2-methanesulfonamidoethyl)phenyl)phenyl)-propyl 2-propanesulfonamide or a pharmaceutically acceptable salt thereof.
10/16/2001US6303814 N-[1,2,4]triazoloazinyl) benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides
10/16/2001US6303790 Process for the preparation of pyridine derivatives
10/16/2001US6303782 Process for preparing benzylnitriles
10/16/2001US6303740 Including structures having a helical, tubular or needle-like morphology; structures may be stabilized by polymerization.
10/16/2001US6303659 Administering adamantane derivative for therapy of rheumatoid arthritis
10/16/2001US6303658 Therapy of ocular hypertension by applying cyclopentane heptenoic acid or heptanoic acid and/or derivative
10/16/2001US6303641 Cyanoamidines as cell proliferation inhibitors
10/16/2001US6303639 Propanolamine derivatives substituted by heterocyclic radicals, processes for their preparation, pharmaceuticals comprising these compounds and their use
10/16/2001US6303611 For therapy of hyperalgesis
10/16/2001US6303602 Useful as analgesic, anesthetic, anti-inflammatory or neuroprotective agent, or for therapy of arthritis, stroke of functional bowel disease
10/16/2001CA2025301C New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase
10/11/2001WO2001074910A2 Ether-amine based polymerization catalysts, compositions and processes using same
10/11/2001WO2001074796A1 SUCCINOYLAMINO HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
10/11/2001WO2001074788A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use
10/11/2001WO2001074780A1 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
10/11/2001WO2001074779A1 Aminopyridines and their use as anticonvulsants and sodium channel blockers
10/11/2001WO2001074778A1 (1-adamantylamino)pyridines and method of their preparation
10/11/2001WO2001074763A1 Aryl and heteroaryl sulfonates
10/11/2001WO2001074753A1 Synthetic derivatives of lunularic acid, medicaments containing said compounds, method for producing the lunularic acid derivatives and the use thereof
10/11/2001WO2001074391A1 Preventives/remedies for kidney diseases
10/11/2001WO2001074180A1 Nutritional supplements for stimulating bone growth
10/11/2001WO2001025210A3 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands
10/11/2001WO2001021714A3 Monoazo dyestuffs useful for colour filters and ink jet printing
10/11/2001WO2000050376A9 Efficient synthesis of alkyl carbonates
10/11/2001WO2000017176A3 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments
10/11/2001US20010029300 Reacting the corresponding oxo compound with an aromatic amine
10/11/2001DE10015866A1 Aryl- und Heteroarylsulfonate Aryl and Heteroarylsulfonate
10/11/2001DE10015525A1 Synthetische Derivate von Lunularsäure, Arzneimittel enthaltend diese Verbindung, Verfahren zur Herstellung der Lunularsäurederivate sowie deren Verwendung Synthetic derivatives of Lunularsäure, to medicaments containing this compound, methods of making them and their use of the Lunularsäurederivate
10/11/2001CA2405132A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use
10/11/2001CA2404545A1 Aryl and heteroaryl sulfonates
10/11/2001CA2404314A1 Succinoylamino heterocycles as inhibitors of a.beta. protein production
10/11/2001CA2403991A1 Aminopyridines and their use as anticonvulsants and sodium channel blockers
10/11/2001CA2403885A1 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
10/10/2001EP1142875A1 Cinnamamide derivatives and drug compositions containing the same
10/10/2001EP1142870A1 Novel ligands of nuclear receptor
10/10/2001EP1142868A1 Amide derivatives
10/10/2001EP1142867A2 Cell adhesion inhibitors
10/10/2001EP1140913A1 Thiourea inhibitors of herpes viruses
10/10/2001EP1140905A1 Heteroaromatic amides as inhibitor of factor xa
10/10/2001EP1140903A1 Aromatic amides
10/10/2001EP1140871A1 Thrombin or factor xa inhibitors
10/10/2001EP1140862A1 THROMBIN OR FACTOR Xa INHIBITORS
10/10/2001EP1140852A1 1,2,3,4-tetrahydronaphthalenes and their pharamaceutical use
10/10/2001EP1140849A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
10/10/2001EP1140848A2 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity
10/10/2001EP1140847A1 Substituted 2-phenylpyridines as herbicides
10/10/2001EP1140846A1 Aspartic protease inhibitors
10/10/2001EP1140845A1 Susbstituted pyridine herbicides
10/10/2001EP1140844A1 Process for the formation of intermediates useful for the preparation of pharmaceuticals
10/10/2001EP1140843A1 Improved pyridine/picoline production process
10/10/2001EP1140840A1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
1 ... 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 ... 633